Testing implementation support strategies to facilitate an evidence-based substance use and mental health care intervention in veterans treatment courts
ISRCTN | ISRCTN13576289 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN13576289 |
Secondary identifying numbers | QUE-20-017-MISSIONCJ |
- Submission date
- 16/12/2022
- Registration date
- 21/12/2022
- Last edited
- 21/12/2022
- Recruitment status
- Recruiting
- Overall study status
- Ongoing
- Condition category
- Mental and Behavioural Disorders
Plain English summary of protocol
Background and study aims
Veterans Treatment Courts (VTCs) were established in 2004 to address the needs of justice-involved Veterans and reduce prison overcrowding. With over 500 VTCs nationally, they offer Veterans an alternative to incarceration and an opportunity to address their behavioral health needs in lieu of jail or prison. Despite the success of VTCs, care can become fragmented between VTCs and VA behavioral health and social programs, particularly for those with multiple service needs. This is often true for justice-involved Veterans with co-occurring MH and SUD, as they make up 60% of VTC cases, and frequently have difficulty engaging in MH and SUD treatment, which often results in a spiraling into unemployment and homelessness, which are themselves strong predictors of reoffending. The VA Veterans Justice Outreach (VJO) Program serves the VTCs and delegates a Veterans Justice Outreach Specialist to the court, who has the responsibility of linking eligible Veterans to VA addiction and other behavioral health services. While VJO has shown great success, high risk clients in VTCs, particularly those with co-occurring disorders could benefit from comprehensive wraparound services to help the Veteran remain engaged in VA and NON-VA care.
Maintaining Independence and Sobriety through Systems Integration, Outreach and Networking - Criminal Justice version (MISSION-CJ) includes a structured wraparound treatment approach delivered by case managers (CMs) and peer specialists (PS), who offer justice involved Veterans with mental health and substance use disorder group psychoeducational therapy sessions, outreach, and linkage support for 6 months. The core MISSION-CJ treatment elements, include: (1) Critical Time Intervention (CTI) (CM and PS deliver assertive outreach); (2) Empowering Prosocial Change (6 structured group sessions for Veterans Treatment Court Participants that promote prosocial thinking and behavior); (3) Dual Recovery Therapy (DRT) (13 weekly structured group sessions delivered by CMs to address MH and SUD problems and modify antisocial cognitions & behaviors); (4) Peer Support Sessions (11 structured group sessions delivered by PSs to reinforce prosocial behavior engagement, and modify antisocial cognitions and behaviors); and (5) Linkage to employment and trauma services as needed (CM/PS facilitate linkages).
In 2016, MISSION was entered into the Substance Abuse and Mental Health Services Administration National Registry of Evidence-Based Programs and Practices. Because of the significant overlap between criminal justice and homelessness among the Veteran population, we modified MISSION, now called MISSION-Criminal Justice (MISSION-CJ) to meet the criminal justice needs of Veterans. We conducted four studies of MISSION-CJ, two in Veterans Treatment courts, one in a mental health court and one in a drug court. These studies demonstrated that participants in MISSION-CJ showed improvements in criminal recidivism, mental health and substance abuse outcomes, employment and optimized linkages to VA and non-VA care. Given these promising results of MISSION and the adaption of criminal justice, an important next step is to identify the most effective implementation strategy, and to work on developing a cost and business case analysis to help with spread and sustainability in VA.
Project Aims:
Aim 1: Identify pre-implementation barriers and facilitators to adopting MISSION-CJ across sites.
Aim 2: Conduct a stepped wedge trial to determine the successful implementation of an educational outreach vs. facilitation.
Aim 3: Develop an implementation Playbook to support sustainment of MISSION-CJ in VTCs.
Who can participate?
Veterans justice outreach specialists and peer support specialists working with Veterans treatment courts, and veterans with substance use disorder and another mental health disorder.
What does the study involve?
This will be a hybrid type III effectiveness-implementation trial utilizing an adaptive design. First, all sites will be trained on MISSION-CJ. Second, a low intensity educational outreach baseline implementation strategy will be offered to help sites deliver MISSION-CJ. Third, every six months, two sites will add on implementation facilitation (higher intensity implementation strategy that includes technical assistance) for 12 months. This design allows us to examine the uptake of MISSION-CJ utilizing educational outreach or implementation facilitation and increased access and engagement in VA/Non-VA care and reduce criminal recidivism among the clients being served be staff delivering MISSION-CJ.
What are the possible benefits and risks of participating?
Benefits of participation include adhering to an evidence-based practice with more fidelity to the model, as well as an opportunity to provide veterans an evidence-based practice to enhance their treatment.
No risks are expected.
Where is the study run from?
VA Bedford Health Care (USA)
When is the study starting and how long is it expected to run for?
October 2020 to December 2025
Who is funding the study?
U.S. Department of Veterans Affairs
Who is the main contact?
Dr David Smelson, david.smelson@va.gov
Contact information
Principal Investigator
VA Bedford Healthcare System
Center for Healthcare Organization and Implementation Research (CHOIR)
200 Springs Road (152)
Bedford
01730
United States of America
0000-0001-9161-9818 | |
Phone | +1 781-825-7778 |
david.smelson@va.gov |
Study information
Study design | Hybrid type III randomized implementation-effectiveness adaptive study design |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Other |
Study type | Other |
Participant information sheet | Not available in web format, please use the contact details to request a patient information sheet. |
Scientific title | Maintaining Independence and Sobriety through Systems Integration, Outreach and Networking - Criminal Justice version |
Study acronym | MISSION-CJ |
Study objectives | Under higher intensity implementation facilitation strategies compared with low-intensity implementation facilitation strategies, Maintaining Independence and Sobriety Through Systems Integration, Outreach, and Networking-Criminal Justice version (MISSION-CJ) will have greater adoption and engagement in Veterans Treatment Court |
Ethics approval(s) | The Veterans Affairs (VA) Bedford Healthcare System Institutional Review Board, in Bedford, Massachusetts, USA determined this study, according to the Veterans Health Administration Handbook 1200.05, to be non-research due to it being a quality improvement initiative for use internal to the VA healthcare system, and not designed to develop or contribute to generalizable knowledge. |
Health condition(s) or problem(s) studied | Co-occurring mental health and substance use disorder, mental health, substance use disorders, recidivism, criminal legal involvement in Veterans enrolled in Veterans Treatment Courts |
Intervention | This will be a hybrid type III effectiveness-implementation trial utilizing an adaptive design. First, all sites will be trained on MISSION-CJ. Second, a low intensity educational outreach baseline implementation strategy will be offered to help sites deliver MISSION-CJ. Third, every six months, two sites will add on implementation facilitation (higher intensity implementation strategy that includes technical assistance) for 12 months. This design allows us to examine the uptake of MISSION-CJ utilizing educational outreach or implementation facilitation and increased access and engagement in VA/Non-VA care and reduce criminal recidivism among the clients being served by staff delivering MISSION-CJ. The study conditions include discontinue (i.e., receive no implementation support), low/passive (i.e., lower intensity facilitation strategies), high intensity facilitation (i.e., increase to more intense implementation strategies). Sites will be randomized based on meeting or not meeting a predefined implementation benchmark. Meeting the implementation benchmark is predefined as conducting at least 15 MISSION-CJ structured curriculum sessions (i.e., a combination of DRT, EPC, and/or Peer Support) and five unstructured outreach sessions. If these components are not met, then sites will be considered as not meeting the implementation benchmark. Those meeting the implementation benchmark will be randomized to either continue to receive low/passive implementation facilitation or discontinue. Those not meeting the implementation benchmark will be randomized to either continue at the current level of implementation facilitation (i.e., low/passive), or to receive more personalized facilitation support (i.e., higher intensity facilitation). MISSION-CJ includes a structured wraparound treatment approach delivered by case managers (CMs) and peer specialists (PS), who offer justice involved Veterans with mental health and substance use disorder group psychoeducational therapy sessions, outreach, and linkage support for 6 months. The core MISSION-CJ treatment elements, include: (1) Critical Time Intervention (CTI) (CM and PS deliver assertive outreach); (2) Empowering Prosocial Change (6 structured group sessions for Veterans Treatment Court Participants that promote prosocial thinking and behavior); (3) Dual Recovery Therapy (DRT) (13 weekly structured group sessions delivered by CMs to address MH and SUD problems and modify antisocial cognitions & behaviors); (4) Peer Support Sessions (11 structured group sessions delivered by PSs to reinforce prosocial behavior engagement, and modify antisocial cognitions and behaviors); and (5) Linkage to employment and trauma services as needed (CM/PS facilitate linkages). |
Intervention type | Behavioural |
Primary outcome measure | Fidelity is measured using the MISSION-CJ fidelity tool which is embedded within the VA's computerized patient record system. which tracks several features of MISSION-CJ (e.g., How many and what type of MISSION-CJ sessions were given by case managers and peer specialists) across all mental health, substance use disorder and social services domains for each Veteran who participates in the Veterans Treatment Court after each MISSION-CJ contact with a case manager or peer specialist. |
Secondary outcome measures | 1. Overdose rate, which is measured as percent of Veterans with an overdose event, each quarter after enrollment in MISSION-CJ services. 2. Linkage to VA and non-VA mental health, measured by mental health care linkage is measured by any mental health care visit (identified in the VA’s electronic medical record system), each quarter after enrollment in MISSION-CJ services. 3. Linkage to VA and non-VA substance use disorder care, measured by linkage to substance use treatment is measured by any substance use visit (identified in the VA’s electronic medical record system), each quarter after enrollment in MISSION-CJ services 4. Criminal recidivism, measured using the number of jail/prison days which will be monitored by searching statewide and federal inmate locator systems and databases, each quarter after enrollment in MISSION-CJ services. |
Overall study start date | 01/10/2020 |
Completion date | 31/12/2025 |
Eligibility
Participant type(s) | Mixed |
---|---|
Age group | Adult |
Sex | Both |
Target number of participants | 20 staff; 400 veterans |
Key inclusion criteria | 1. Veterans Justice Outreach Specialists and Peer Support Specialists working with Veterans Treatment Courts (VTC) Veteran inclusion criteria: 1. VA service-connected and enrolled in a VTC affiliated with a VA site within one of the four VISNs; 2. Meets Diagnostic and Statistical Manual of Mental Disorders, 5th Edition diagnostic criteria of International Classification of Diseases, 10th Revision for a current substance use disorder(s) (mild – severe) and a co-occurring mental health disorder(s) (including anxiety, mood, or a psychotic spectrum disorders); and 3. Is willing to participate in MISSION-CJ services. VTC enrollment varies and can be as high as 45 veterans per VTC. |
Key exclusion criteria | Ineligible for VA healthcare |
Date of first enrolment | 01/11/2020 |
Date of final enrolment | 30/09/2025 |
Locations
Countries of recruitment
- United States of America
Study participating centres
Manchester
03104
United States of America
Leeds
01053
United States of America
Wilmington
19805
United States of America
Aurora
80045
United States of America
Fresno
93703
United States of America
North Las Vegas
89086
United States of America
Honolulu
96819
United States of America
Sponsor information
Hospital/treatment centre
200 Springs Road
Bedford
01730
United States of America
Phone | +1 781-687-2000 |
---|---|
karen.smith9@va.gov | |
Website | http://www.bedford.va.gov |
Funders
Funder type
Government
Government organisation / National government
- Alternative name(s)
- Department of Veterans Affairs, United States Department of Veterans Affairs, US Department of Veterans Affairs, U.S. Dept. of Veterans Affairs, Veterans Affairs, Veterans Affairs Department, VA, USDVA
- Location
- United States of America
Results and Publications
Intention to publish date | 31/12/2026 |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not expected to be made available |
Publication and dissemination plan | Planned publication in a high-impact peer-reviewed journal. The study protocol will be available in the future. |
IPD sharing plan | The participant-level data are not expected to be made available due to confidentiality reasons. Data will be stored on a secure server behind the Department of Veterans Affairs firewall. |
Editorial Notes
21/12/2022: Trial's existence confirmed by Department of Veterans Affairs.